Return to Course Library



Jeffrey C. Weinreb, MD, FACR, FISMRM, FSCBT/MR
Professor of Radiology and Biomedical Imaging
Vice Chair for Strategic Planning and Innovation
Yale School of Medicine
Director, MRI Services
Yale New-Haven Hospital
New Haven, CT


Update on Gadolinium Deposition
and the Safety of MRI Contrast Agents

Coming to Indianapolis! (note:  this is not a webinar)
Thursday | October 26, 2017

A certified one-hour lecture for radiologists, radiologic technologists, neuroradiologists, medical physicists, and referring physicians

JW Marriott Indianapolis
10 S West Street 
Indianapolis, IN  46204


On-site Meeting in Indianapolis
(note:  this is not a webinar)

Physician Credit: 1.0 AMA PRA Category 1
RT Credit: 1.0 ARRT Category A
Tuition: Free
5:30 - 6:00 pm Registration and light refreshments
6:00 - 7:00 pm Lecture and Discussion
    7:00 pm Adjourn

Data regarding gadolinium deposition in patients who have undergone contrast-enhanced MRI are rapidly evolving. Further research is needed to evaluate the clinical significance, if any, of these findings. In the meantime, radiologists and referring physicians must ensure informed decision-making about the benefits and potential risks to patients undergoing a contrast-enhanced MRI examination.

This lecture will discuss the physicochemical properties of gadolinium-based contrast agents, review pertinent literature, and discuss how recent data are relevant to clinical practice.

Educational Objectives
After completing this activity, the participants should be better able to:

  • Describe how the physicochemical properties and classification of GBCAs may affect patient safety
  • Discuss recent studies reporting the discovery of gadolinium deposits in patients who have undergone contrast-enhanced MRI exams
  • Summarize what is known and not known at this time regarding the clinical significance of gadolinium deposition in patients
  • Implement current FDA and ACR guidelines for GBCA usage

Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Radiologic Technologist Continuing Education
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.

Registration Information
REGISTER EARLY, a limited number of seats are available. Onsite registration is subject to space availabliity.

  • Click ENROLL NOW and follow the registration instructions to register with ICPME.
  • You will receive an email from ICPME confirming your registration.

How to Receive Credit

  1. Attend the entire lecture.
  2. Sign into your account at and click on the course title.
  3. Click the Evaluation tab on the left, complete the evaluation, and submit.
  4. Click the Certificate tab on the left, select the certificate type desired, and print.

Your Certificate of Credit will remain in your account at as a permanent record of your participation.

Jeffrey C. Weinreb, MD, FACR, FISMRM, FSCBT/MR
Professor of Radiology and Biomedical Imaging
Vice Chair for Strategic Planning and Innovation
Yale School of Medicine
Director, MRI Services
Yale New-Haven Hospital
New Haven, CT

After graduating Phi Beta Kappa from the Massachusetts Institute of Technology, Dr. Weinreb received his medical degree from the Mount Sinai School of Medicine. He has held faculty positions at University of Texas Southwestern Medical School, Columbia College for Physicians and Surgeons, and New York University School of Medicine, where he was Director of MRI for 15 years and led a group that pioneered the development of Body MRI, Breast MRI, and MRA. Yale has been his home since 2002.

Dr. Weinreb is currently Professor of Radiology and Biomedical Imaging at the Yale School of Medicine and Chief of MRI at Yale-New Haven Hospital. He is a leading authority on MRI contrast agents, MRI safety, and the use of MRI for the abdomen (focusing on the liver), and pelvis (focusing on the prostate). A noted educator and lecturer, he has presented more than 900 invited lectures and has been a frequent Visiting Professor throughout the world. Dr. Weinreb has authored/co-authored more than 200 published manuscripts and 3 textbooks, and he has been on the editorial boards of numerous medical journals. As Chairman of the American College of Radiology Commission on Quality and Safety, Dr. Weinreb spearheaded efforts to improve the quality of medical imaging in the USA. Recently, he led an international effort to develop PI-RADS v2 (Prostate Imaging Reporting and Data System Version 2) to standardize the acquisition, interpretation, and reporting of prostate MRI, and the manuscript was recognized as the Best Clinical Research Paper published in European Urology for 2016. He has served as President of the SCBT/MR, President of the New York Roentgen Society, and Vice President of the ACR, and he currently chairs ACR RADS Steering Committee. He is the recipient of the 2017 ACR Gold Medal Award.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Jeffrey C. Weinreb, MD, FACR, FISMRM, FSCBT/MR has received consulting fees from Bracco and Guerbet.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino Victoria Phoenix, BS
Trace Hutchison, PharmD Jan Schultz, RN, MSN, CHCP
Linda McLean, MS Judi Smelker-Mitchek, MBA, MSN, RN
Samantha Mattiucci, PharmD, CHCP  

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of products and devices that are not indicated by the FDA. The planners of this activity do not recommend the use of any products or devices outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Representatives from the International Center for Postgraduate Medical Education (ICPME) will be on site to assist you with meeting management and CME administration. If you require auxiliary aids or services identified in the Americans with Disabilities Act, please contact our office at (607) 257-5860 x10 at least 14 days prior to the this educational activity.

Queries and Comments
We welcome and encourage your comments on all aspects of this educational activity.

Please address your queries or comments regarding this activity to:
International Center for Postgraduate Medical Education
33 Thornwood Drive, Suite 400
Ithaca, NY 14850
Phone: 607-257-5860
Visit us on the web at


This activity is supported by an independent educational grant from Bayer HealthCare Pharmaceuticals.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.